Keywords: USA, In vitro diagnostics market, Roche, Abbott, iData
Battle for share of US $8.5 billion in vitro diagnostic market
Article | 08 June 2011
The US in-vitro diagnostic market, including immunochemistry, molecular diagnostics, point-of-care testing, blood-donor screening, hematology and hemostasis is valued at over $8.5 ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
